← Leaderboards
Lisa M. Ellerby
Buck Institute For Age Research
$31,198,180
Attributed
$40,398,020
Total exposure
16
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$55,912,177 · 17
By mechanism
R01$22,430,977 · 8
P01$20,341,513 · 4
T32$8,952,736 · 1
RL1$2,250,132 · 1
R21$1,085,405 · 2
R56$851,414 · 1
Top collaborators
- Judith Campisi17 shared
- Diana Michele Bautista5 shared
- Rachel Beth Brem5 shared
- Simon Melov5 shared
- Eric M Verdin5 shared
- Pankaj Kapahi1 shared
- Pan Li1 shared
- Cristina Montagna1 shared
Most similar at Buck Institute For Age Research
Same institution · by research overlap
- Pankaj Kapahi$21,454,019
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposNeuronsCellsAge RelatedNeurodegenerative DisordersBrainMouse ModelPhenotypeAgingInduced Pluripotent Stem CellProgramsAffectNerve DegenerationS DiseasePathologyHuntington DiseaseMutantMolecularProteinsDisease ProgressionGenesDementiaLongevityAstrocytes
Grant awards (90)
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias$2,808,473
P01 · FY2025 · AG · contact PI
Training in Basic Research on Aging and Age-Related Disease$834,401
T32 · FY2025 · AG · contact PI
Identifying Factors Regulating Medium Spiny Neuron Differentiation or Maintenance as Therapeutic Targets for Huntington's Disease using Induced Pluripotent Stem Cells$785,686
R01 · FY2025 · NS · contact PI
Cell autonomous and non-autonomous mechanisms in Alzheimer's disease and related dementias$501,273
P01 · FY2025 · AG · contact PI
Genomic Instability-Induced Senescence in Brain Aging and Alzheimer's Disease$432,280
R01 · FY2025 · AG
ADRD Induced pluripotent stem cell/organoid core$333,036
P01 · FY2025 · AG · contact PI
Administration and statistical/bioinformatics core$276,055
P01 · FY2025 · AG · contact PI
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias$115,399
P01 · FY2025 · AG · contact PI
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias$2,872,219
P01 · FY2024 · AG · contact PI
Training in Basic Research on Aging and Age-Related Disease$842,182
T32 · FY2024 · AG · contact PI
Identifying Factors Regulating Medium Spiny Neuron Differentiation or Maintenance as Therapeutic Targets for Huntington's Disease using Induced Pluripotent Stem Cells$809,186
R01 · FY2024 · NS · contact PI
Cell autonomous and non-autonomous mechanisms in Alzheimer's disease and related dementias$514,600
P01 · FY2024 · AG · contact PI
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias$502,928
P01 · FY2024 · AG · contact PI
ADRD Induced pluripotent stem cell/organoid core$339,834
P01 · FY2024 · AG · contact PI
Administration and statistical/bioinformatics core$281,691
P01 · FY2024 · AG · contact PI
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias$115,399
P01 · FY2024 · AG · contact PI
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias$65,114
P01 · FY2024 · AG · contact PI
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias$27,841
P01 · FY2024 · AG · contact PI
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias$2,878,430
P01 · FY2023 · AG · contact PI
Training in Basic Research on Aging and Age-Related Disease$785,981
T32 · FY2023 · AG · contact PI
Genetic dissection of trait variation between long-diverged mouse species$722,510
R01 · FY2023 · NS
Cell autonomous and non-autonomous mechanisms in Alzheimer's disease and related dementias$517,596
P01 · FY2023 · AG · contact PI
ADRD Induced pluripotent stem cell/organoid core$339,832
P01 · FY2023 · AG · contact PI
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias$112,210
P01 · FY2023 · AG
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias$111,434
P01 · FY2023 · AG
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias$46,513
P01 · FY2023 · AG
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias$2,884,435
P01 · FY2022 · AG
Genetic dissection of trait variation between long-diverged mouse species$953,697
R01 · FY2022 · NS
Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells$879,592
R01 · FY2022 · AG · contact PI
Training in Basic Research on Aging and Age-Related Disease$653,397
T32 · FY2022 · AG
Cell autonomous and non-autonomous mechanisms in Alzheimer's disease and related dementias$520,490
P01 · FY2022 · AG · contact PI
ADRD Induced pluripotent stem cell/organoid core$339,832
P01 · FY2022 · AG · contact PI
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias$83,527
P01 · FY2022 · AG
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias$2,890,235
P01 · FY2021 · AG
Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells$879,592
R01 · FY2021 · AG · contact PI
Determining the role of OXR1 in aging and Alzheimer's disease$851,414
R56 · FY2021 · AG
Genetic dissection of trait variation between long-diverged mouse species$804,822
R01 · FY2021 · NS
Training in Basic Research on Aging and Age-Related Disease$726,862
T32 · FY2021 · AG
Cell autonomous and non-autonomous mechanisms in Alzheimer's disease and related dementias$523,285
P01 · FY2021 · AG · contact PI
ADRD Induced pluripotent stem cell/organoid core$339,832
P01 · FY2021 · AG · contact PI
Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells$879,592
R01 · FY2020 · AG · contact PI
Training in Basic Research on Aging and Age-Related Disease$715,392
T32 · FY2020 · AG
Genetic dissection of trait variation between long-diverged mouse species$637,695
R01 · FY2020 · NS
Identifying Factors Regulating Medium Spiny Neuron Differentiation or Maintenance as Therapeutic Targets for Huntington's Disease using Induced Pluripotent Stem Cells$614,226
R01 · FY2020 · NS · contact PI
Genetic Correction of Mutant Huntingtin in Vivo$424,375
R01 · FY2020 · NS · contact PI
Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells$879,592
R01 · FY2019 · AG · contact PI
Genetic dissection of trait variation between long-diverged mouse species$695,973
R01 · FY2019 · NS
Training in Basic Research on Aging and Age-Related Disease$675,432
T32 · FY2019 · AG
Identifying Factors Regulating Medium Spiny Neuron Differentiation or Maintenance as Therapeutic Targets for Huntington's Disease using Induced Pluripotent Stem Cells$616,060
R01 · FY2019 · NS · contact PI
Evaluation of the role of RNA toxicity in SCA2 pathogenesis using genome editing in patient iPSCs$505,808
R21 · FY2019 · NS
Genetic Correction of Mutant Huntingtin in Vivo$424,375
R01 · FY2019 · NS · contact PI
Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells$879,592
R01 · FY2018 · AG · contact PI
Training in Basic Research on Aging and Age-Related Disease$647,654
T32 · FY2018 · AG
Identifying Factors Regulating Medium Spiny Neuron Differentiation or Maintenance as Therapeutic Targets for Huntington's Disease using Induced Pluripotent Stem Cells$621,319
R01 · FY2018 · NS · contact PI
Genetic Correction of Mutant Huntingtin in Vivo$424,375
R01 · FY2018 · NS · contact PI
Identifying Factors Regulating Medium Spiny Neuron Differentiation or Maintenance as Therapeutic Targets for Huntington's Disease using Induced Pluripotent Stem Cells$649,866
R01 · FY2017 · NS · contact PI
Genetic Correction of Mutant Huntingtin in Vivo$424,375
R01 · FY2017 · NS · contact PI
Training in basic research on aging and age-related disease$251,800
T32 · FY2017 · AG
Identifying Factors Regulating Medium Spiny Neuron Differentiation or Maintenance as Therapeutic Targets for Huntington's Disease using Induced Pluripotent Stem Cells$699,638
R01 · FY2016 · NS · contact PI
Training in basic research on aging and age-related disease$549,826
T32 · FY2016 · AG
Genetic Correction of Mutant Huntingtin in Vivo$424,375
R01 · FY2016 · NS · contact PI
Matrix Metalloproteinases: Therapeutic Targets For Huntington's Disease$424,375
R01 · FY2016 · NS · contact PI
Comprehensive Synaptome Proteomics Targeting Protein Expression and PTMs in HD$275,682
R21 · FY2016 · NS · contact PI
Training in basic research on aging and age-related disease$584,414
T32 · FY2015 · AG
Matrix Metalloproteinases: Therapeutic Targets For Huntington's Disease$424,375
R01 · FY2015 · NS · contact PI
Comprehensive Synaptome Proteomics Targeting Protein Expression and PTMs in HD$303,915
R21 · FY2015 · NS · contact PI
Training in basic research on aging and age-related disease$581,329
T32 · FY2014 · AG
Matrix Metalloproteinases: Therapeutic Targets For Huntington's Disease$420,130
R01 · FY2014 · NS · contact PI
Training in basic research on aging and age-related disease$558,999
T32 · FY2013 · AG
Matrix Metalloproteinases: Therapeutic Targets For Huntington's Disease$424,375
R01 · FY2013 · NS · contact PI
Training in basic research on aging and age-related disease$545,067
T32 · FY2012 · AG
Huntington's Disease and Neurogenesis$408,385
R01 · FY2012 · NS · contact PI
HDACs in Neurodegeneration and Aging$432,135
RL1 · FY2011 · NS · contact PI
Huntington's Disease and Neurogenesis$408,385
R01 · FY2011 · NS · contact PI
HDACs in Neurodegeneration and Aging$475,565
RL1 · FY2010 · NS · contact PI
Huntington's Disease and Neurogenesis$412,551
R01 · FY2010 · NS · contact PI
HDACs in Neurodegeneration and Aging$32,932
RL1 · FY2010 · NS · contact PI
HDACs in Neurodegeneration and Aging$436,500
RL1 · FY2009 · NS · contact PI
Huntington's Disease and Neurogenesis$416,719
R01 · FY2009 · NS · contact PI
Huntington's Disease and Neurogenesis$440,219
R01 · FY2008 · NS · contact PI
HDACs in Neurodegeneration and Aging$436,500
RL1 · FY2008 · NS · contact PI
HDACs in Neurodegeneration and Aging$436,500
RL1 · FY2007 · NS · contact PI
Triplet Repeat Disease:Requirement for Caspase Cleavage$425,378
R01 · FY2007 · NS · contact PI
Triplet Repeat Disease:Requirement for Caspase Cleavage$544,170
R01 · FY2006 · NS · contact PI
Triplet Repeat Disease:Requirement for Caspase Cleavage$557,265
R01 · FY2005 · NS
Triplet Repeat Disease:Requirement for Caspase Cleavage$40,740
R01 · FY2005 · NS
Triplet Repeat Disease:Requirement for Caspase Cleavage$426,888
R01 · FY2004 · NS
Triplet Repeat Disease:Requirement for Caspase Cleavage$448,625
R01 · FY2003 · NS
TRIPLET REPEAT DISEASE: REQUIREMENT FOR CASPASE CLEAVAGE$322,747
R01 · FY2001 · NS
TRIPLET REPEAT DISEASE: REQUIREMENT FOR CASPASE CLEAVAGE$322,857
R01 · FY2000 · NS